This panel of experts will discuss how the practice of FDA law has changed since they started their careers. They will compare how working in the industry has evolved and what can be expected in the future, as well as whether the FDCA can continue to address an ever-growing and changing industry. A reception will follow the panel presentation. This program is limited to FDLI members who are a part of NFDL, summer associates, and student members.
Karen R. Gally, Vice President, and General Counsel, Otsuka America Pharmaceutical, Inc.
Lewis Grossman, Ph.D., JD, Professor of Law at American University
Sonali P. Gunawardhana, Chief Counsel, FDA & Regulatory Law, McKesson Corporation and Member, FDLI Board of Directors
Stuart Pape, Chair, FDA Practice, Polsinelli PC
Moderated by Jennifer L. Bragg, Partner, Life Sciences and Health Care; Litigation, Skadden, Arps, Slate, Meagher & Flom LLP
May 23, 2022
4:45–6:30 PM ET
4:45-5:00 PM | Check-In
5:00-5:45 PM| Panel Discussion
5:45-6:30 PM | Reception
The Panel Discussion will be indoors. In the event of inclement weather, the Panel Discussion and Reception will be indoors.
This program is limited to FDLI members who are a part of NFDL, summer associates, and student members. This complimentary program includes a light reception. Please register by May 20 to reserve your spot.
New to Food and Drug Law Group
The New to Food and Drug Law Group (NFDL) offers young professionals with up to six years of experience an opportunity to connect, learn from their peers, and enhance their skills. Individuals affiliated with member organizations, those employed by the government, and law students are encouraged to participate.
For questions, please contact Bianca Cardona.